This progressive loss of the expression of megalin and other endocytic receptors, including the glucose and sodium transporter SGC2 and phosphate transporters, is proposed to account for apical dedifferentiation leading to the development of Fanconi syndrome, which is not corrected by cysteamine treatment in cystinotic patients. Here, LRP2 is linked to Fanconi renotubular syndrome.